Evaluation
ECHA and the Member States evaluate the information submitted by companies to examine the quality of the registration dossiers and the testing proposals and to clarify if a given substance constitutes a risk to human health or the environment.
Evaluation under REACH focuses on three different areas:
- Examination of testing proposals submitted by registrants
- Compliance check of the dossiers submitted by registrants
- Substance evaluation
Once the evaluation is done, registrants may be required to submit further information on the substance.
Evaluation Report 2011
- Evaluation under REACH - Progress Report 2011 [PDF] [EN]
- Summary of Evaluation Report 2011 [PDF] [EN]
See also
- Evaluation process
- Title VI of the REACH Regulation (EC) No 1907/2006
- ECHA's Procedure on Dossier Evaluation[PDF]
- Evaluation progress report (2010)[PDF]
- Evaluation progress report (2009)[PDF]
- Evaluation progress report (2008)[PDF]
- European Centre for the Validation of Alternative Methods (ECVAM)
- Webinars
- Member State Committee
- Information Toolkit
Related Guidance
- Guidance on dossier and substance evaluation[PDF]
- Guidance on priority setting for evaluation[PDF]
- Guidance on information requirements and chemical safety assessment
- Guidance on registration[PDF]
- Substance Evaluation fact sheet[PDF]
- Guidance for identification and naming of substances[PDF]
- Guidance on data sharing[PDF]
- Guidance on the application of the CLP Criteria[PDF]
Related documents
- Practical guide 1. How to report in vitro data[PDF]
- Practical guide 2. How to report weight of evidence[PDF]
- Practical guide 3. How to report robust study summaries[PDF]
- Practical guide 4. How to report data waiving[PDF]
- Practical guide 5. How to report (Q)SARs[PDF]
- Practical guide 6. How to report read-across and categories[PDF]
- Practical guide 10. How to avoid unnecessary testing on animals[PDF]
- Practical guide 12: How to communicate with ECHA in dossier evaluation[PDF]